Camptosar / Irinotecan Hydrochloride

Camptosar is a medication used to treat colorectal cancer. It is manufactured by Pharmacia Corp. and was approved by the Food and Drug Administration in 2000. Camptosar has been approved as a first-line treatment for colorectal cancer patients, and is used in combination with three other drugs, fluorouracil, irinotecan, and leucoverin. The combination of these drugs may create side effects such as, diarrhea, nausea, vomiting, a depletion of white blood cells, and bloodinfections.

Recently, two independent studies suspended enrollment of new patients due to alarming new information about the drug combinations. New studies show "an unexpectedly high rate of death" associated with Camptosar.

A spokesperson for Pharmacia stressed that over 15,000 patients have been treated with Camptosar since its approval, and all of the company's studies show that Camptosar can prolong life.

See your doctor if you have experienced serious side effects associated with Camptosar. In addition, it may be important to contact an attorney who can help you protect your legal rights. Please keep in mind that there may be time limits within which you must commence suit.

Who We AreThe Legal Examiner offers both bloggers and readers the opportunity to share their thoughts and opinions on all things law. From news on current legislative efforts to practical guidance on everyday legal issues, The Legal Examiner will have it covered. Learn More